AI for Drug Discovery
JAMA+ AI Conversations
00:00
Balancing Public and Proprietary Data
Roy asks about data sources; Ajamete explains using public datasets like UK Biobank alongside rigorous in-house CRISPR perturbation data.
Play episode from 03:53
Transcript
